Observations from GCP Sponsor Inspections
Kevin Anderson, Director, Global Clinical Operations, Alexion Pharmaceuticals, offers a perspective on what he has...
Is the GAIN Act Stimulating Antibiotic R&D?
Christopher J. Pace, PhD, Director of Infectious Diseases, GlobalData, assesses the impact of the GAIN...
The Future of Pfizer’s $5B Brand is in Jeopardy
Maura Musciacco, MSc, Neurology & Ophthalmology Director, GlobalData, assesses what the future holds for Pfizer’s...
The Top 5: November 2018
CTA highlights the best articles from the month of November 2018
Expert Insights: Abbvie’s EU Outlook Dims as Discounts Deepen on Humira Biosimilars
Rose Joachim, PhD, Immunology Analyst, GlobalData, examines the impact of newly approved biosimilars on AbbVie’s...
The Ongoing Fight Against Diabetes
On World Diabetes Day, CTA’s Harry Parsons delves in to the disease, looking at the...
How to Conduct a Diabetes Trial – Lessons Learned
Jacqueline Mardell, Ascendis Pharma, recounts experiences from a multinational type 2 diabetes trial and draws...
Surveying the Challenges of Preclinical Development
CTA’s Adeola Coker delves into the key issues facing preclinical trials ahead of Arena International’s...
Industry Viewpoints: The Continual Rise of Direct-to-Patient
Michael Sparozic, Lead Trial Supply Operations Manager, Sanofi, address the merits of direct-to-patient shipping to...
Patient-Centric Trials of the Future
Robert Greene, Founder and President, HungerNdThirst Foundation, looks at patient-centric trials of the future